# FDA Inspection 1031331 - Miranda Gogishvili - October 18, 2017

Source: https://www.keypedia.com/records/fda_inspections/miranda-gogishvili/6de58a92-13ae-44dc-84a2-00c582ef3c20
Source feed: FDA_Inspections

> FDA Inspection 1031331 for Miranda Gogishvili on October 18, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1031331
- Company Name: Miranda Gogishvili
- Inspection Date: 2017-10-18
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1179074 - 2022-09-02](https://www.keypedia.com/records/fda_inspections/miranda-gogishvili/35279700-65a6-4c60-8ae7-05aea39d03fb)

Company: https://www.keypedia.com/companies/miranda-gogishvili/f88f92eb-ba80-4a1c-bd85-d66a5dff095c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c